In last trading session, Olema Pharmaceuticals Inc (NASDAQ:OLMA) saw 2.2 million shares changing hands with its beta currently measuring 2.11. Company’s recent per share price level of $3.33 trading at -$0.01 or -0.30% at ring of the bell on the day assigns it a market valuation of $227.55M. That closing price of OLMA’s stock is at a discount of -399.1% from its 52-week high price of $16.62 and is indicating a premium of 1.5% from its 52-week low price of $3.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.35 million shares which gives us an average trading volume of 1.05 million if we extend that period to 3-months.
For Olema Pharmaceuticals Inc (OLMA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Olema Pharmaceuticals Inc (NASDAQ:OLMA) trade information
Upright in the red during last session for losing -0.30%, in the last five days OLMA remained trading in the red while hitting it’s week-highest on Friday, 03/28/25 when the stock touched $3.33 price level, adding 21.83% to its value on the day. Olema Pharmaceuticals Inc’s shares saw a change of -42.88% in year-to-date performance and have moved -19.57% in past 5-day. Olema Pharmaceuticals Inc (NASDAQ:OLMA) showed a performance of -20.71% in past 30-days. Number of shares sold short was 8.69 million shares which calculate 11.26 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 27 to the stock, which implies a rise of 87.67% to its current value. Analysts have been projecting 27 as a low price target for the stock while placing it at a high target of 27. It follows that stock’s current price would drop -710.81% in reaching the projected high whereas dropping to the targeted low would mean a loss of -710.81% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -83.00% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -1.50% while estimates for its earnings growth in next 5 years are of -4.08%.
Olema Pharmaceuticals Inc (NASDAQ:OLMA)’s Major holders
Insiders are in possession of 3.21% of company’s total shares while institution are holding 101.72 percent of that, with stock having share float percentage of 105.09%. Investors also watch the number of corporate investors in a company very closely, which is 101.72% institutions for Olema Pharmaceuticals Inc that are currently holding shares of the company. BVF INC/IL is the top institutional holder at OLMA for having 9.14 million shares of worth $98.85 million. And as of 2024-06-30, it was holding 16.2322 of the company’s outstanding shares.
The second largest institutional holder is PARADIGM BIOCAPITAL ADVISORS LP, which was holding about 7.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 14.0428 of outstanding shares, having a total worth of $85.52 million.
